UK markets closed

Pacira Pharmaceuticals, Inc. (PCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.13-0.24 (-0.85%)
At close: 04:00PM EDT
27.43 -0.70 (-2.49%)
After hours: 04:05PM EDT
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
153,298
104,139
585,578
99,957
-
Other short-term investments
125,283
184,512
70,831
421,705
-
Total cash
278,581
288,651
656,409
521,662
-
Net receivables
105,556
98,397
96,318
53,046
-
Inventory
104,353
96,063
98,550
64,650
-
Other current assets
21,504
15,223
14,771
12,265
-
Total current assets
509,994
498,334
866,048
651,623
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
370,253
371,869
350,051
289,540
-
Accumulated depreciation
-135,306
-117,480
-85,240
-78,360
-
Net property, plant and equipment
234,947
254,389
264,811
211,180
-
Equity and other investments
2,410
37,209
0
95,459
-
Goodwill
163,243
163,243
145,175
99,547
-
Intangible assets
483,258
540,546
623,968
96,521
-
Other long-term assets
36,049
27,170
21,987
14,019
-
Total non-current assets
1,064,392
1,182,866
1,209,305
622,890
-
Total assets
1,574,386
1,681,200
2,075,353
1,274,513
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
8,641
33,648
374,700
149,648
-
Accounts payable
15,698
15,220
10,543
10,431
-
Taxes payable
-
0
429
114
1,333
Accrued liabilities
42,561
63,587
82,064
48,772
-
Other current liabilities
-
-
-
14,736
18,179
Total current liabilities
97,383
147,774
521,118
253,328
-
Non-current liabilities
Long-term debt
513,796
655,823
674,530
313,030
-
Deferred revenues
-
-
10,125
0
-
Other long-term liabilities
38,271
37,791
77,570
17,442
-
Total non-current liabilities
606,873
758,416
823,827
401,497
-
Total liabilities
704,256
906,190
1,344,945
654,825
-
Stockholders' equity
Common stock
46
46
45
44
-
Retained earnings
-106,796
-148,751
-211,895
-253,875
-
Accumulated other comprehensive income
247
-380
167
318
-
Total stockholders' equity
870,130
775,010
730,408
619,688
-
Total liabilities and stockholders' equity
1,574,386
1,681,200
2,075,353
1,274,513
-